Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Rossari Biotech has informed that the Company will be participating in the investor and analyst meet/conference/events ‘Dolat Capital Annual Conference’ on Wednesday, September 18, 2024. The discussion(s) and presentation at the meeting will be on the financial and other information available to the public or covered in the ‘Earnings Presentation’, which was submitted to the Stock Exchange(s) vide its letter dated July 21, 2024 and uploaded on its website. No Unpublished Price Sensitive Information will be shared at the above-mentioned meeting(s).